Antisense oligonucleotides: translation from mouse models to human neurodegenerative diseases

Schoch, Kathleen M., Miller, Timothy M.·2017·Neuron

DOI 10.1016/j.neuron.2017.04.010

Cited by (274)

Items 101–200 of 274

Therapeutic news in ALS
Philippe Corcia, S. Beltran, S.E. Bakkouche, Philippe Couratier · 2021 · Revue Neurologique
Therapeutic Strategies in Huntington’s Disease: From Genetic Defect to Gene Therapy
Anamaria Jurcău, Maria Carolina Jurcău · 2022 · Biomedicines
Effect of intrathecal NIS-lncRNA antisense oligonucleotides on neuropathic pain caused by nerve trauma, chemotherapy, or diabetes mellitus
Chun‐Hsien Wen, Tolga Berkman, Xiang Li, Shibin Du, Gokulapriya Govindarajalu, Haijun Zhang, Alex Bekker, Steve Davidson, Yuan‐Xiang Tao · 2022 · British Journal of Anaesthesia
Glial cells in the driver seat of leukodystrophy pathogenesis
Luis Garcia, Julia Liao Hacker, Sunetra Sase, Laura Ann Adang, Akshata Almad · 2020 · Neurobiology of Disease
Antisense Oligonucleotide Reverses Leukodystrophy in Canavan Disease Mice
Vanessa L. Hull, Yan Wang, Travis Burns, Sheng Zhang, Sarah Sternbach, Jennifer Ann McDonough, Fuzheng Guo, David Pleasure · 2020 · Annals of Neurology
Crosstalk between lncRNAs in the apoptotic pathway and therapeutic targets in cancer
Nasim Ebrahimi, Sahar Parkhideh, Setare Samizade, Alireza Nasr Esfahani, Sahar Samsami, Elnaz Yazdani, Samaneh Adelian, Siavash Rahimian Chaleshtori, Kamal Shahamiri, Amirhossein Ahmadi et al. · 2022 · Cytokine & Growth Factor Reviews
Change of intracellular calcium level causes acute neurotoxicity by antisense oligonucleotides via CSF route
Chunyan Jia, Su Su Lei Mon, Ying Yang, Maho Katsuyama, Kie Yoshida‐Tanaka, Tetsuya Nagata, Kotaro Yoshioka, Takanori Yokota · 2022 · Molecular Therapy — Nucleic Acids
Genetic approaches to the treatment of inherited neuromuscular diseases
Bhavya Ravi, Anthony Antonellis, Charlotte J. Sumner, Andrew P. Lieberman · 2019 · Human Molecular Genetics
LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer
Brianne M. Cruickshank, Marie‐Claire D. Wasson, Justin M. Brown, Wasundara Fernando, Jaganathan Venkatesh, Olivia L. Walker, Fiorella Morales-Quintanilla, Margaret L. Dahn, Dejan Vidovic, Cheryl A. Dean et al. · 2021 · Cancers
Precision Medicine Approaches for Infantile-Onset Developmental and Epileptic Encephalopathies
Kenneth Alexis Myers, Ingrid Eileen Scheffer · 2021 · The Annual Review of Pharmacology and Toxicology
MTDH antisense oligonucleotides reshape the immunosuppressive tumor microenvironment to sensitize Hepatocellular Carcinoma to immune checkpoint blockade therapy
Jing-Lei Wan, Biao Wang, Mei-Lan Wu, Jie Li, Ruo-Mu Gong, Li-Na Song, Hanshuo Zhang, Gui‐Qi Zhu, Shi-Ping Chen, Jialiang Cai et al. · 2022 · Cancer Letters
Immunogenicity for Antisense Oligonucleotides: A Risk-Based Assessment
Christopher C. Stebbins, Marco Petrillo, Lauren F. Stevenson · 2019 · Bioanalysis
Routine Cerebrospinal Fluid (CSF) Parameters in Patients With Spinal Muscular Atrophy (SMA) Treated With Nusinersen
Claudia D. Wurster, Jan Christoph Koch, Isabell Cordts, Jens Dreyhaupt, Markus Otto, Željko Uzelac, Simon Witzel, Benedikt Winter, Tugrul Kocak, Michael F. H. Schocke et al. · 2019 · Frontiers in Neurology
RNA-Targeted Therapies and Amyotrophic Lateral Sclerosis
Stéphane Mathis, Gwendal Le Masson · 2018 · Biomedicines
Refining the concept of GFAP toxicity in Alexander disease
Albee Messing · 2019 · Journal of Neurodevelopmental Disorders
Next-Generation Sequencing Technologies and Neurogenetic Diseases
Hui Sun, Xiao-Rong Shen, Zi-Bing Fang, Zongzhi Jiang, Xiaojing Wei, Ziyi Wang, Xuefan Yu · 2021 · Life
mRNA Processing: An Emerging Frontier in the Regulation of Pancreatic β Cell Function
Nicole D. Moss, Lori Sussel · 2020 · Frontiers in Genetics
Gap Junction Channels of Innexins and Connexins: Relations and Computational Perspectives
Alejandro Sánchez, Carlos Castro, Dora‐Luz Flores, Everardo Gutiérrez-López, Pierre Baldi · 2019 · International Journal of Molecular Sciences
DRPLA: understanding the natural history and developing biomarkers to accelerate therapeutic trials in a globally rare repeat expansion disorder
Aiysha Chaudhry, Alkyoni Athanasiou‐Fragkouli, Henry Houlden · 2020 · Journal of Neurology
Effects of Alpha-Synuclein Targeted Antisense Oligonucleotides on Lewy Body-Like Pathology and Behavioral Disturbances Induced by Injections of Pre-Formed Fibrils in the Mouse Motor Cortex
Sydney Weber Boutros, Jacob Raber, Vivek K. Unni · 2021 · Journal of Parkinson s Disease
Modulation of insulin secretion by RBFOX2-mediated alternative splicing
Nicole D. Moss, Kristen L. Wells, Alexandra Theis, Yong-Kyung Kim, Aliya F Spigelman, Xiong Liu, Patrick E. MacDonald, Lori Sussel · 2023 · Nature Communications
Recent advances in molecular therapies for neurological disease: triplet repeat disorders
Pedro Gonzalez‐Alegre · 2019 · Human Molecular Genetics
Excess Lipin enzyme activity contributes to TOR1A recessive disease and DYT-TOR1A dystonia
Ana Catarina Carapinha Cascalho, Joyce Foroozandeh, Lise Hennebel, Jef Swerts, Christine Klein, Stef Rous, Beatriz Dominguez Gonzalez, Antonio Pisani, Maria Meringolo, Sandra F. Gallego et al. · 2020 · Brain
The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders
Philippine Aupy, Lucía Echevarría, Karima Relizani, Aurélie Goyenvalle · 2017 · Biomedicines
miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson’s disease
Vasanti Suvarna, Kajal Deshmukh, Manikanta Murahari · 2022 · Frontiers in Pharmacology
Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1‐linked amyotrophic lateral sclerosis mice
Seiji Watanabe, Okiru Komine, Fumito Endo, Keisuke Wakasugi, Koji Yamanaka · 2017 · Journal of Neurochemistry
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoform
Guy Helman, Asako Takanohashi, Tracy L. Hagemann, Ming Der Perng, Marzena Walkiewicz, Sarah Woidill, Sunetra Sase, Zachary Cross, Yangzhu Du, Ling Zhao et al. · 2020 · Human Mutation
Targeting the 5′ untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
Audrey M. Winkelsas, Christopher Grunseich, George G. Harmison, Katarzyna Chwalenia, Carlo Rinaldi, Suzan M. Hammond, Kory R. Johnson, Mélissa Bowerman, Sukrat Arya, Kevin Talbot et al. · 2021 · Molecular Therapy — Nucleic Acids
Novel Therapeutic Horizons: SNCA Targeting in Parkinson’s Disease
A. M. Caramiello, Valentina Pirota · 2024 · Biomolecules
Targeted intraspinal injections to assess therapies in rodent models of neurological disorders
Kevin S. Chen, Lisa M. McGinley, Osama Nezar Kashlan, John M. Hayes, Elizabeth S. Bruno, Josh S. Chang, Faye E. Mendelson, Maegan A. Tabbey, Karl K. Johe, Stacey A. Sakowski et al. · 2019 · Nature Protocols
Cerebrospinal Fluid and Clinical Profiles in Adult Type 2–3 Spinal Muscular Atrophy Patients Treated with Nusinersen: An 18-Month Single-Centre Experience
Giammarco Milella, Alessandro Introna, Eustachio D’Errico, Angela Fraddosio, Gaspare Scaglione, Antonella Morea, Maria Ucci, Maddalena Ruggieri, Mariangela Mastrapasqua, Marisa Megna et al. · 2021 · Clinical Drug Investigation
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
Jie Liu, Zhen‐Ni Guo, Xiu‐Li Yan, Yi Yang, Shuo Huang · 2021 · Frontiers in Aging Neuroscience
The Potential Role of Dysregulated miRNAs in Alzheimer’s Disease Pathogenesis and Progression
Ankur A. Patel, Ganepola A.P. Ganepola, John R. Rutledge, David H. Chang · 2019 · Journal of Alzheimer s Disease
Targeting Transferrin Receptor to Transport Antisense Oligonucleotides Across the Blood-Brain Barrier
Scarlett J. Barker, Mai B. Thayer, Chaeyoung Kim, David Tatarakis, Matthew J. Simon, Rebekah L. Dial, Lizanne Nilewski, Robert C. Wells, Yinhan Zhou, Megan E. Afetian et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Oligonucleotide-based therapeutics for neurodegenerative disorders: Focus on antisense oligonucleotides
Heba Mohamed Mansour, Aiman Saad El-Khatib · 2025 · European Journal of Pharmacology
Gene specific therapies – the next therapeutic milestone in neurology
Dávid Brenner, Albert Christian Ludolph, Jochen Hans Weishaupt · 2020 · Neurological Research and Practice
Antisense oligonucleotides targeting the miR-29b binding site in the GRN mRNA increase progranulin translation
Geetika Aggarwal, Subhashis Banerjee, Spencer A. Jones, Yousri Benchaar, Jasmine Bélanger, Myriam Sévigny, Denise M. Smith, Michael L. Niehoff, Monica Pavlack, Ian Mitchelle S. de Vera et al. · 2023 · Journal of Biological Chemistry
Oligonucleotide correction of an intronic TIMMDC1 variant in cells of patients with severe neurodegenerative disorder
Raman Kumar, Mark A Corbett, Nicholas J. C. Smith, Daniella Helena Hock, Zoya Kikhtyak, Liana N. Semcesen, Atsushi Morimoto, Sangmoon Lee, David A. Stroud, Joseph G. Gleeson et al. · 2022 · npj Genomic Medicine
Types of RNA therapeutics
Pouya Goleij, Mehregan Babamohamadi, Aryan Rezaee, Pantea Majma Sanaye, Mohammad Amin Khazeei Tabari, Sarvin Sadreddini, Reza Arefnezhad, Hossein Motedayyen · 2024 · Progress in molecular biology and translational science
New Roles for Canonical Transcription Factors in Repeat Expansion Diseases
Lindsey D. Goodman, Nancy M. Bonini · 2019 · Trends in Genetics
Inhibition of Glycogen Synthase Kinase 3β as a Treatment for the Prevention of Cognitive Deficits after a Traumatic Brain Injury
Susan A. Farr, Michael L. Niehoff, Vijaya B. Kumar, Deborah A. Roby, John Edward Morley · 2019 · Journal of Neurotrauma
A novel and translational role for autophagy in antisense oligonucleotide trafficking and activity
Joseph Ochaba, Andrew F. Powers, Kaitlyn Tremble, Sarah Greenlee, Noah M. Post, John E. Matson, A. Robert MacLeod, Shuling Guo, Mariam Aghajan · 2019 · Nucleic Acids Research
Correction of a Splicing Mutation Affecting an Unverricht-Lundborg Disease Patient by Antisense Therapy
Liliana Matos, Ana Joana Duarte, Diogo Ribeiro, João Chaves, Olga Amaral, Sandra Alves · 2018 · Genes
A cell-penetrant peptide blocking C9ORF72 -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins
Lydia M. Castelli, Ya-Hui Lin, Álvaro Sánchez-Martínez, Aytaç Gül, Kamallia Mohd Imran, Adrian Higginbottom, Santosh Kumar Upadhyay, Nóra M. Márkus, Raquel Rua Martins, Johnathan Cooper‐Knock et al. · 2023 · Science Translational Medicine
Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human MAPT Gene Expression
Madhuri Chakravarthy, Suxiang Chen, Tao Wang, Rakesh Naduvile Veedu · 2020 · Genes
Targeting Alternative Splicing as a Potential Therapy for Episodic Ataxia Type 2
Fanny Jaudon, Sımona Baldassari, Ilaria Musante, Agnes Thalhammer, Federico Zara, Lorenzo A. Cingolani · 2020 · Biomedicines
Therapeutic Mechanism of Nucleic Acid Drugs
Lianxiao Liu, Haixia Gao, Chuanxin Guo, Tao Liu, Ning Li, Qijun Qian · 2021 · ChemistrySelect
Antisense oligonucleotides and nucleic acids generate hypersensitive platelets
Alexander Zaslavsky, Mackenzie P. Adams, Xiu Cao, Adriana Aya Yamaguchi, James Henderson, Peter Busch-Østergren, Aaron M. Udager, Sethuramasundaram Pitchiaya, Benjamin E. Tourdot, Tadas Kasputis et al. · 2021 · Thrombosis Research
RNA-based therapies for neurodegenerative disease: Targeting molecular mechanisms for disease modification
Vishal Bhati, Sonima Prasad, Atul Kabra · 2025 · Molecular and Cellular Neuroscience
Novel regulators of PrP C expression as potential therapeutic targets in prion diseases
Arianna Colini Baldeschi, Silvia Vanni, Marco Zattoni, Giuseppe Legname · 2020 · Expert Opinion on Therapeutic Targets
An Overview of Mitochondrial Protein Defects in Neuromuscular Diseases
Federica Marra, Paola Lunetti, Rosita Curcio, Francesco Massimo Lasorsa, Loredana Capobianco, Vito Porcelli, Vincenza Dolce, Giuseppe Fiermonte, Pasquale Scarcia · 2021 · Biomolecules
Apoptosis signal-regulating kinase 1 (ASK1) as a therapeutic target for neurological diseases
Satoshi Takenaka, Takao Fujisawa, Hidenori Ichijo · 2020 · Expert Opinion on Therapeutic Targets
Sequence-specific 2'-O-methoxyethyl antisense oligonucleotides activate human platelets through glycoprotein VI, triggering formation of platelet-leukocyte aggregates
Martina H. Lundberg Slingsby, Prakrith Vijey, I‐Ting Tsai, Harvey G. Roweth, Genevieve C. Couldwell, Adrian R. Wilkie, Hans J. Gaus, Jazana M. Goolsby, Ross A. Okazaki, Brooke E. Terkovich et al. · 2021 · Haematologica
Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer’s disease
Lina Vandermeulen, Ivana Geric, Laura Fumagalli, Mohamed Kreir, Ashley Lu, Annelies Nonneman, Jessie Premereur, Leen Wolfs, Rafaela Policarpo, Nicola Fattorelli et al. · 2024 · Molecular Neurodegeneration
Modelling Neuromuscular Diseases in the Age of Precision Medicine
Alfina A. Speciale, Ruth Ellerington, Thomas Goedert, Carlo Rinaldi · 2020 · Journal of Personalized Medicine
Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
Yi Chen, Curt Mazur, Yi Luo, Linhong Sun, Mingdi Zhang, Alex McCampbell, Giulio Srubek Tomassy · 2019 · Journal of Visualized Experiments
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, Li Mi, Xian Wu, Xiaohui Huang, Ajing Xu, Yan Liu, Jian Zhang · 2024 · Neural Regeneration Research
Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
Stacie C. Weninger, Bjørn Sperling, Robert Alexander, Magnus Ivarsson, Fiona M. Menzies, Peter Powchik, Christopher J. Weber, C. Anthony Altar, Ronald G. Crystal, Stephen J. Haggarty et al. · 2020 · Alzheimer s & Dementia Translational Research & Clinical Interventions
A novel strategy for retention prediction of nucleic acids with their sequence information in ion-pair reversed phase liquid chromatography
Chao Liang, Jun‐qin Qiao, Hong‐zhen Lian · 2018 · Talanta
A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models
Susumu Ikenoshita, Kazuya Matsuo, Yasushi Yabuki, Kosuke Kawakubo, Sefan Asamitsu, Karin Hori, Shingo Usuki, Yuki Hirose, Toshikazu Bando, Kimi Araki et al. · 2023 · Journal of Clinical Investigation
In vivo distribution of cerebrospinal fluid tracer in human upper spinal cord and brain stem
Erik Melin, Are Hugo Pripp, Per Kristian Eide, Geir André Ringstad · 2023 · JCI Insight
N6-methyladenosine modification of a parvovirus-encoded small noncoding RNA facilitates viral DNA replication through recruiting Y-family DNA polymerases
Kang Ning, Junxing Zhao, Zehua Feng, Soo Yeun Park, Shane McFarlin, Fang Cheng, Ziying Yan, Jingxin Wang, Jianming Qiu · 2024 · Proceedings of the National Academy of Sciences
Development of Antisense Oligonucleotide Gapmers for the Treatment of Huntington’s Disease
Tejal Aslesh, Toshifumi Yokota · 2020 · Methods in molecular biology
Emerging strategies for the genetic dissection of gene functions, cell types, and neural circuits in the mammalian brain
Ling Gong, Xue Liu, Jinyun Wu, Miao He · 2021 · Molecular Psychiatry
Artificial microRNA suppresses C9ORF72 variants and decreases toxic dipeptide repeat proteins in vivo
Gabriela Toro Cabrera, Katharina E. Meijboom, Abbas Abdallah, Hélène Tran, Zachariah W. Foster, Alexandra Weiss, Nicholas Wightman, Rachel E. Stock, Tania F. Gendron, Alisha M. Gruntman et al. · 2023 · Gene Therapy
Platelet Activation by Antisense Oligonucleotides (ASOs) in the Göttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny
Allan Valenzuela, Miriam Ayuso, Laura A. Buyssens, Chloé Bars, Chris J. Van Ginneken, Yann Tessier, Steven J.M. Van Cruchten · 2023 · Pharmaceutics
Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders
Flavien Bizot, Adeline Vulin, Aurélie Goyenvalle · 2020 · Drugs
CRISPR/Cas9-generated mouse model with humanizing single-base substitution in the Gnao1 for safety studies of RNA therapeutics
Anna V. Polikarpova, Tatiana V. Egorova, Evgenii A. Lunev, Alexandra A. Tsitrina, Svetlana G. Vassilieva, Irina M. Savchenko, Yulia Yu. Silaeva, Alexey V. Deykin, Maryana V. Bardina · 2023 · Frontiers in Genome Editing
Development of Antisense Oligonucleotide Gapmers for the Treatment of Dyslipidemia and Lipodystrophy
Tejal Aslesh, Toshifumi Yokota · 2020 · Methods in molecular biology
Upregulation of Linc00284 Promotes Lung Cancer Progression by Regulating the miR-205-3p/c-Met Axis
Sheng Wang, Weixi Guo, Fang Lu, Hongming Liu, Rongmu Xia, Feng Dong · 2021 · Frontiers in Genetics
Surface Design Options in Polymer- and Lipid-Based siRNA Nanoparticles Using Antibodies
Michael Gabel, Annkathrin Knauss, Dagmar Fischer, Markus Friedrich Neurath, Benno Weigmann · 2022 · International Journal of Molecular Sciences
Epigenetic regulatory modifications in genetic and sporadic frontotemporal dementia
Chiara Fenoglio, Elio Angelo Scarpini, Daniela Galimberti · 2018 · Expert Review of Neurotherapeutics
Suppression of Kv3.3 channels by antisense oligonucleotides reverses biochemical effects and motor impairment in spinocerebellar ataxia type 13 mice
Yalan Zhang, Imran H. Quraishi, Heather McClure, Luis A. Williams, YungChih Cheng, Siddharth Kale, Graham T. Dempsey, Sudhir Agrawal, David J. Gerber, Owen B. McManus et al. · 2021 · The FASEB Journal
The expanding neurological phenotype of DNM1L-related disorders
Michael F. Wangler, Nurit Assia Batzir, Laurie A. Robak, Mary Kay Koenig, Carlos A. Bacino, Fernando Scaglia, Hugo Jozef Bellen · 2018 · Brain
miRNA- and lncRNA-Based Therapeutics for Non-Hodgkin’s Lymphoma: Moving towards an RNA-Guided Precision Medicine
Mara Fernandes, Herlander Marques, Ana Luísa Teixeira, Rui Medeiros · 2021 · Cancers
The Pathobiology of Cerebrovascular Lesions in CADASIL Small Vessel Disease
Anne Joutel · 2025 · Basic & Clinical Pharmacology & Toxicology
Antisense oligonucleotide therapy in amyotrophic lateral sclerosis
Gergo Erdi-Krausz, Pamela J. Shaw · 2025 · Current Opinion in Neurology
SOD1-targeting therapies for neurodegenerative diseases: a review of current findings and future potential
John Franklin, Mimoun Azzouz, Pamela J. Shaw · 2020 · Expert Opinion on Orphan Drugs
Advances of long non-coding RNAs in osteoclast differentiation and osteoporosis
Wenjie Liu, Yunhui Zhang, Quanfeng Li, Xinglang Wang, Yanfeng Wu, Huiyong Shen, Peng Wang · 2024 · Pathology - Research and Practice
RNA structure in alternative splicing regulation: from mechanism to therapy
Nengcheng Bao, Zhechao Wang, Jiayan Fu, Haiyang Dong, Yongfeng Jin · 2024 · Acta Biochimica et Biophysica Sinica
Oligonucleotides: A novel area of interest for drug delivery in neurodegenerative diseases
Khalid Saad Alharbi, Mohammad Arshad Javed Shaikh, Obaid Afzal, Abdulmalik Saleh Alfawaz Altamimi, Waleed Hassan Almalki, Imran Ahmed Kazmi, Fahad Ahmed Al-Abbasi, Sami Ibrahim Alzarea, Malakapogu Ravindra Babu, Sachin Kumar Singh et al. · 2022 · Journal of Drug Delivery Science and Technology
Nanoparticles for Brain Drug Delivery
Sérgio R. S. Veloso, Paula M. T. Ferreira, José Alberto Martins, Paulo J. G. Coutinho, Elisabete M. S. Castanheira · 2020
Multi-Faceted Role of Histone Methyltransferase Enhancer of Zeste 2 (EZH2) in Neuroinflammation and Emerging Targeting Options
Sotirios Moraitis, Christina Piperi · 2025 · Biology
Pathophysiological implications of RNP granules in frontotemporal dementia and ALS
Perlina Desai, Rina Bandopadhyay · 2020 · Neurochemistry International
Cortical projection neurons as a therapeutic target in multiple sclerosis
Tatjana Beutel, Julia Dzimiera, Hannah Kapell, Maren Engelhardt, Achim Gass, Lucas Schirmer · 2020 · Expert Opinion on Therapeutic Targets
MicroRNA inhibition using antimiRs in acute human brain tissue sections
Gareth Morris, Elena Langa, Conor Fearon, Karen Conboy, Kelvin Lau E. How, Amaya Sanz‐Rodriguez, Donncha F. O’Brien, Kieron J. Sweeney, Austin Lacey, Norman Delanty et al. · 2022 · Epilepsia
Development of a Novel Peptide Nucleic Acid Probe for the Detection of Legionella spp. in Water Samples
Montserrat Nachér-Vázquez, ANA BEATRIZ DE OLIVEIRA BARBOSA, Inês Armelim, Andreia Sofia Azevedo, Gonçalo Nieto Almeida, Cristina Pizarro, Nuno F. Azevedo, Carina Almeida, Laura Cerqueira · 2022 · Microorganisms
A fluorescent splice-switching mouse model enables high-throughput, sensitive quantification of antisense oligonucleotide delivery and activity
Amy E. Byrnes, Filip Roudnicky, Alvin Gogineni, Allison Soung, Monica Xiong, Margaret R. Hayne, Tiffany M. Heaster, Whitney Shatz-Binder, Sara L. Domínguez, Jose Imperio et al. · 2024 · Cell Reports Methods
The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders
M Cappella, Sahar Elouej, Maria Grazia Biferi · 2021 · Frontiers in Cell and Developmental Biology
Elucidating brain transport pathways and cell type-dependent gene silencing of a durable lipid–siRNA conjugate administered into cerebrospinal fluid
Sorets, Alexander G, Schwensen, Katrina R, Francini, Nora, Kjar, Andrew, Abdulrahman, Adam M, Shostak, Alena, Katdare, Ketaki A, Schoch, Kathleen M, Cowell, Rebecca P, Park, Joshua C et al. · 2025 · Nucleic Acids Research
Contribution of DNA / RNA Structures Formed by Expanded CGG / CCG Repeats Within the FMR1 Locus in the Pathogenesis of Fragile X‐Associated Disorders
Izabela Broniarek, Daria Niewiadomska, Krzysztof Sobczak · 2024 · Wiley Interdisciplinary Reviews - RNA
Breaking the resistance: a narrative review of the evolution from traditional drugs to precision therapies in epilepsy
Tirath Patel, Fathimathul Henna, Ashfaq Ahmad, Ayesha Ahmad, Noor Ul Huda, Syed Aaraiz Ul Hassan, Aiman Muhammad, Amna Javed, Maryem Filal, Arej Iltaf et al. · 2025 · Annals of Medicine and Surgery
Role of Cav2.3 (R-type) Calcium Channel in Pain and Analgesia: A Scoping Review
Marcella de Amorim Ferreira, Juliano Ferreira · 2023 · Current Neuropharmacology
Antisense‐induced downregulation of major circadian genes modulates the expression of histone deacetylase‐2 (HDAC‐2) and CREB‐binding protein (CBP) in the medial shell region of nucleus accumbens of mice exposed to chronic excessive alcohol consumption
Rishi Sharma, Meet S Parikh, Vaibhav Kumar Mishra, Anshul Soni, Sofia Rubi, Pradeep Kumar Sahota, Mahesh M. Thakkar · 2021 · Journal of Neurochemistry
A Chemical Biology Perspective to Therapeutic Regulation of RNA Splicing in Spinal Muscular Atrophy (SMA)
Lei Zhang, Frank Abendroth, Olalla Vázquez · 2022 · ACS Chemical Biology
Genetic-Based Treatment Strategies for Muscular Dystrophy and Congenital Myopathies
Andrew R. Findlay, Conrad Chris Weihl · 2022 · CONTINUUM Lifelong Learning in Neurology
Systemic administration of NIS-lncRNA antisense oligonucleotide alleviates neuropathic pain
Tolga Berkman, Xiang Li, Yingping Liang, Anna Korban, Alex Bekker, Yuan‐Xiang Tao · 2023 · Neuroscience Letters
Activation of dopamine D2 receptors in the medial shell region of the nucleus accumbens increases Per1 expression to enhance alcohol consumption
Rishi Sharma, Meet S Parikh, Vaibhav Kumar Mishra, Pradeep Kumar Sahota, Mahesh M. Thakkar · 2022 · Addiction Biology
Neurocognitive and Perceptual Processing in Genetic Mouse Models of Schizophrenia: Emerging Lessons
Anastasia Diamantopoulou, Joseph A. Gogos · 2019 · The Neuroscientist
Evaluating the efficacy of purchased antisense oligonucleotides to reduce mouse and human tau in vivo
Pranav Vemula, Kathleen M. Schoch, Timothy M. Miller · 2023 · Frontiers in Molecular Neuroscience